Company Filing History:
1 out of 181 
1 out of 2 Years Active: 2025
Title: Adam Bartlomiej Sikora: Innovator in Cancer Treatment
Introduction
Adam Bartlomiej Sikora is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. His work focuses on addressing the challenges posed by drug-resistant cancer cells.
Latest Patents
Adam Bartlomiej Sikora holds a patent for "Targeting redox-active pyridinium cations to mitochondria to inhibit proliferation of drug-resistant cancer cells." This invention provides novel mito-pyridinium compounds, prodrugs, and their uses for the treatment of cancer, particularly targeting drug-resistant forms of the disease. He has 1 patent to his name.
Career Highlights
Throughout his career, Sikora has worked with esteemed institutions such as the Medical College of Wisconsin, Inc. and Lodz University of Technology. His research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Sikora has collaborated with notable colleagues, including Jacek Michal Zielonka and Balaraman Kalyanaraman, to further his research and development efforts in the field of cancer therapeutics.
Conclusion
Adam Bartlomiej Sikora's innovative work in cancer treatment exemplifies the impact of dedicated research on overcoming significant medical challenges. His contributions continue to inspire advancements in the fight against drug-resistant cancer.